805 related articles for article (PubMed ID: 18407790)
1. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.
McCredie MR; Sharples KJ; Paul C; Baranyai J; Medley G; Jones RW; Skegg DC
Lancet Oncol; 2008 May; 9(5):425-34. PubMed ID: 18407790
[TBL] [Abstract][Full Text] [Related]
2. Consequences in women of participating in a study of the natural history of cervical intraepithelial neoplasia 3.
McCredie MR; Paul C; Sharples KJ; Baranyai J; Medley G; Skegg DC; Jones RW
Aust N Z J Obstet Gynaecol; 2010 Aug; 50(4):363-70. PubMed ID: 20716265
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity in CIN3 diagnosis.
Schiffman M; Rodríguez AC
Lancet Oncol; 2008 May; 9(5):404-6. PubMed ID: 18452848
[No Abstract] [Full Text] [Related]
4. Outcomes for women without conventional treatment for stage 1A (microinvasive) carcinoma of the cervix.
Paul C; Sharples KJ; Baranyai J; Jones RW; Skegg DC
Aust N Z J Obstet Gynaecol; 2018 Jun; 58(3):321-329. PubMed ID: 29405269
[TBL] [Abstract][Full Text] [Related]
5. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
6. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
[TBL] [Abstract][Full Text] [Related]
7. Long-term observational approach in women with histological diagnosis of cervical low-grade squamous intraepithelial lesion: an Italian multicentric retrospective cohort study.
Ciavattini A; Serri M; Di Giuseppe J; Liverani CA; Gardella B; Papiccio M; Delli Carpini G; Morini S; Clemente N; Sopracordevole F
BMJ Open; 2019 Jul; 9(7):e024920. PubMed ID: 31272971
[TBL] [Abstract][Full Text] [Related]
8. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
9. Are Women with Antecedent Low-Grade Cytology and <CIN2 Findings in Colposcopy Being Overmanaged?
Piedmonte S; Tsang K; Jembere N; Murphy J; McCurdy B; Sacco J; Kupets R
J Obstet Gynaecol Can; 2022 Oct; 44(10):1054-1060. PubMed ID: 35948169
[TBL] [Abstract][Full Text] [Related]
10. Cytological follow-up of women older than 50 years with high-grade cervical smear treated by large loop excision.
Das N; Sutton V; Bevan J; Brinkmann D; Woolas R
J Low Genit Tract Dis; 2009 Jul; 13(3):165-8. PubMed ID: 19550214
[TBL] [Abstract][Full Text] [Related]
11. Risks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management: a population-based cohort study.
Tai YJ; Chen YY; Hsu HC; Chiang CJ; You SL; Chen CA; Cheng WF;
J Gynecol Oncol; 2018 Jul; 29(4):e55. PubMed ID: 29770625
[TBL] [Abstract][Full Text] [Related]
12. The borderline cervical smear: colposcopic and biopsy outcome.
al-Nafussi A; Rebello G; al-Yusif R; McGoogan E
J Clin Pathol; 2000 Jun; 53(6):439-44. PubMed ID: 10911801
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.
Katki HA; Kinney WK; Fetterman B; Lorey T; Poitras NE; Cheung L; Demuth F; Schiffman M; Wacholder S; Castle PE
Lancet Oncol; 2011 Jul; 12(7):663-72. PubMed ID: 21684207
[TBL] [Abstract][Full Text] [Related]
14. Early detection of CIN3 and cervical cancer during long-term follow-up using HPV/Pap smear co-testing and risk-adapted follow-up in a locally organised screening programme.
Luyten A; Buttmann-Schweiger N; Luyten K; Mauritz C; Reinecke-Lüthge A; Pietralla M; Meijer CJ; Petry KU
Int J Cancer; 2014 Sep; 135(6):1408-16. PubMed ID: 24519782
[TBL] [Abstract][Full Text] [Related]
15. The use of screening episodes linked to CIN3 and invasive cancer registrations to study outcomes from the NHS Cervical Screening Programme.
Blanks RG; Moss SM; Coleman DA; Addou S; Swerdlow AJ
Cytopathology; 2009 Jun; 20(3):154-60. PubMed ID: 19207309
[TBL] [Abstract][Full Text] [Related]
16. The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women.
Loopik DL; IntHout J; Ebisch RMF; Melchers WJG; Massuger LFAG; Siebers AG; Bekkers RLM
Gynecol Oncol; 2020 Apr; 157(1):195-201. PubMed ID: 31973912
[TBL] [Abstract][Full Text] [Related]
17. Clinical analysis of cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia.
He Y; Zhao Q; Geng YN; Yang SL; Yin CH; Wu YM
Medicine (Baltimore); 2017 Apr; 96(17):e6700. PubMed ID: 28445274
[TBL] [Abstract][Full Text] [Related]
18. Findings and outcome of teenage women referred for colposcopy at Christchurch Women's Hospital, New Zealand.
Sykes P; Harker D; Peddie D
N Z Med J; 2005 Mar; 118(1211):U1350. PubMed ID: 15778751
[TBL] [Abstract][Full Text] [Related]
19. Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality.
Strander B; Hällgren J; Sparén P
BMJ; 2014 Jan; 348():f7361. PubMed ID: 24423603
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
